CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 413 enrolled
Drug / intervention
Trident® Ceramic Insert/Trident® AD HA Acetabular Shell +2 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00960206
NCT00960206N/ACompleted

Post-Approval Study of the ABC and Trident® Systems

Stryker Orthopaedics·interventional·Posted Aug 17, 2009·Updated Feb 3, 2017

In Brief

A clinical study evaluating Trident® Ceramic Insert/Trident® AD HA Acetabular Shell, Alumina Insert/PSL® Microstructured Acetabular Shell or Secur-Fit® HA PSL® Acetabular Shell, and 1 other intervention for Arthroplasty, Replacement, Hip. Completed, enrolled 413 participants across 6 sites.

Detailed Summary

The purpose of the Post Approval Study of the ABC and Trident® systems is to continue to demonstrate the safety and efficacy of the alumina-on-alumina bearing surfaces combined with the appropriate shell in a cementless application.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedAug 17, 2009
Enrollment StartMar 1, 2003
Primary CompletionOct 1, 2010
TodayJul 2, 2026
Enrollment to primary: 7.6 yearsPosted 16.9 years ago

Interventions

Trident® Ceramic Insert/Trident® AD HA Acetabular Shelldevice

Trident® Ceramic Insert/Trident® AD HA Acetabular Shell

Alumina Insert/PSL® Microstructured Acetabular Shell or Secur-Fit® HA PSL® Acetabular Shelldevice

Alumina Insert/PSL® Microstructured Acetabular Shell or Secur-Fit® HA PSL® Acetabular Shell

OmniFit® Series II Insert/OmniFit® PSL® Microstructured Acetabular Shelldevice

OmniFit® Series II Insert/OmniFit® PSL® Microstructured Acetabular Shell